OBJECTIVE:
Fetal excessive exposure to glucocorticoids may "program" cardiometabolic risk. Placental 11 b-hydroxysteroid dehydrogenase 2 (11b-HSD2) serves as the barrier to prevent fetal overexposure to maternal glucocorticoids. It has not been explored whether placental 11b-HSD2 levels are associated with cardiometabolic health in postnatal life. STUDY DESIGN: In a prospective birth cohort study of 246 motherinfant pairs, we measured placental 11b-HSD2, maternal (32-35 weeks of gestation) and cord plasma cortisol concentrations. The primary outcomes were homeostasis model assessment of insulin resistance (HOMA-IR) and mean artery blood pressure (BP) in infants at age 1-year. Other outcomes included fasting insulin, HOMA b-cell function, systolic and diastolic BP, carotid intima-media thickness and skinfold thickness (triceps and subscapular) at age 1-y.
RESULTS: Placental 11b-HSD2 levels were negatively correlated with HOMA-IR (r¼-0.17, p¼0.021) and fasting insulin (r¼-0.18, p¼0.017), and marginally negatively correlated to systolic BP (r¼-0.16, p¼0.057), but not correlated to HOMA-b, diastolic or mean artery BP, carotid intima-media thickness and skinfold thickness (all p>0.1) in infants at age 1-y. Cord plasma cortisol was negatively correlated to skinfold thickness (r¼-0.20, p¼0007), but not correlated to other outcomes at age 1-y. Maternal plasma cortisol was positively correlated with maximal carotid intima-media thickness (r¼0.20, p¼0.03), but not correlated with other outcomes. Adjusting for maternal and infant characteristics, the associations were similar. CONCLUSION: Placental 11b-HSD2 may be negatively associated with insulin resistance in infancy. Placental 11b -HSD2 levels may have relevance for postnatal metabolic health. Independent cohort studies are required to confirm this novel finding.
739 Postpartum health service utilization by mothers of infants admitted to neonatal intensive care OBJECTIVE: Mothers of infants admitted to the neonatal intensive care unit (NICU) must recover from birth while attending to a critically ill infant. These mothers also have higher rates of chronic disease and perinatal complications than mothers of well babies (MWB). We sought to quantify postpartum health utilization by NICU mothers, compared with MWB. STUDY DESIGN: We conducted a retrospective cohort study of mothers delivering liveborn infants at North Carolina Women's Hospital between 7/1/2014 and 6/30/2016. MWB were defined as mothers of infants not admitted to the NICU. NICU mothers were defined as mothers with one or more infants admitted to the NICU. We further subtyped NICU mothers into two groups: Mothers of medically fragile infants (MMFI), defined as NICU length of stay 3 days, and mothers of transiently ill infants (MTII), defined as NICU stays <3 days. We ascertained postpartum health service utilization through encounter data recorded in the UNC Health System Epic Electronic Medical Record (EMR) between discharge from the birth hospitalization and 12 weeks postpartum. We used Poisson regression to compare encounter counts and by encounter type, adjusting for mode of delivery, race/ethnicity, payer status, and maternal age. When differences were found between NICU mothers and MWB, we further compared utilization for MMFI vs. MTII. RESULTS: During the study period, 6849 mothers met criteria for inclusion, of whom 5768 were MWB, 743 were MMFI, and 338 were MTII,. Of these 6849 women, 4349 had at least one encounter in the UNC system during the 12-week postpartum period, comprising 9540 encounters. In crude analyses, NICU mothers were more likely to experience each type of encounter, compared with MWB (Table) . In adjusted analyses, utilization rates remained significantly higher for NICU mothers for all encounter types other than emergency room visits. Exclusion of women without any postpartum encounters in the UNC Health System did not materially change our results. When we compared MTII with MMFI, we found that MTII had higher rates of outpatient office visits (adj RR 1.29, 95% CI 1.07-1.55) and psychiatry visits (adj RR 1.63, 95% CI 1.13-2.35). CONCLUSION: Mothers of NICU infants utilize health care at a higher rate in the postpartum period, compared with MWB. OBJECTIVE: To determine whether methadone, buprenorphine, or detoxification treatment is the most cost-effective approach to the management of opioid use disorder (OUD) during pregnancy. STUDY DESIGN: A decision analytic model compared the cost-effectiveness of initiation of methadone, buprenorphine, or detoxification in treating OUD during pregnancy. Women were assumed to be appropriate candidates for all three treatment strategies. Probabilities, costs, and utilities were determined from the existing literature. Incremental cost-effective ratios (ICERs) for each strategy were calculated and an ICER of $100,000/QALY was used to define cost effectiveness. One-way sensitivity analyses and a Monte Carlo probabilistic sensitivity analysis were performed. RESULTS: Using baseline estimates, initiation of buprenorphine was more effective at a lower cost than either methadone or detoxification; thus, detoxification was dominated by both methadone and buprenorphine (Table) . Based on a nationwide estimate of 20,000 pregnant women affected by OUD annually, buprenorphine use led to a cost savings of 179 million dollars when compared to methadone and 1.49 billion dollars when compared to detoxification. In one-way sensitivity analyses, methadone became the most costeffective strategy when the medication cost of buprenorphine exceeded 337 dollars/month (169% of the base case estimate) or if the incidence of relapse among women on buprenorphine was higher than 35% (422% of the base case estimate). Monte Carlo analyses revealed that buprenorphine was always cost-effective compared with the other strategies and dominated the other strategies 99.7% of the time. CONCLUSION: Buprenorphine is more cost-effective than either methadone or detoxification as treatment for OUD during pregnancy when all treatment options are medically appropriate. This finding was robust in sensitivity analyses. OBJECTIVE: Pregnancy outcomes for women with diabetes mellitus (DM) are improved by preconception care, and access to preconception care is enhanced by insurance coverage. We therefore sought to determine whether expanded access to care through Medicaid after enactment of the Affordable Care Act was associated with improved birth outcomes in women with pregestational DM.
